CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells

International Journal of Cancer

Volumn 134, Issue 1, 2014, Pages 55-64

  Nishioka, Chie ^a,b   Ikezoe, Takayuki ^a   Yang, Jing ^a   Nobumoto, Atsuya ^a   Kataoka, Sayo ^a   Tsuda, Masayuki ^a   Udaka, Keiko ^a   Yokoyama, Akihito ^a  

^a KOCHI UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

AML; CD82; IL 10; leukemia stem cells; STAT5

Indexed keywords

CD82 ANTIGEN; INTERLEUKIN 10; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; STAT5A PROTEIN;

18S GENE; ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER STEM CELL; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; IL 10 GENE; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RNA ISOLATION; SEQUENCE ANALYSIS; STAT5A GENE;

AML; CD82; IL-10; LEUKEMIA STEM CELLS; STAT5;

ANIMALS; ANTIGENS, CD82; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; HETEROGRAFTS; HUMANS; INTERLEUKIN-10; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED NOD; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84885947286     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28348     Document Type: Article

References (30)

1. Bonnet D, Dick JE,. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7.
2. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44.
3. Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007; 25: 1315-21.
4. Taussig DC, Miraki-Moud F, Anjos-Afonso F, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008; 112: 568-75.
5. Sarry JE, Murphy K, Perry R, et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc- deficient mice. J Clin Invest 2011; 121: 384-95.
6. Thorén LA, Liuba K, Bryder D, et al. Kit regulates maintenance of quiescent hematopoietic stem cells. J Immunol 2008; 180: 2045-53.
7. Yoshihara H, Arai F, Hosokawa K, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007; 1: 685-97.
8. Qian H, Buza-Vidas N, Hyland CD, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 2007; 1: 671-84.
9. Nervi B, Ramirez P, Rettig MP, et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 2009; 113: 6206-14.
10. Wang Z, Li G, Tse W, et al. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 2009; 113: 4856-65.
11. Yoshihara H, Arai F, Hosokawa K, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007; 1: 685-97.
12. Qian H, Buza-Vidas N, Hyland CD, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 2007; 1: 671-84.
13. Schepers H, Van Gosliga D, Wierenga AT, et al. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. Blood 2007; 110: 2880-8.
14. Moore MA, Dorn DC, Schuringa JJ, et al. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol 2007; 35: 105-16.
15. Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-79.
16. Liu Y, Wei SH, Ho AS, et al. Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152: 1821-9.
17. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155: 1079-90.
18. Kotenko SV, Krause CD, Izotova LS, et al. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16: 5894-903.
19. - acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Int J Cancer 2013; 132: 2006-19.
20. Nishioka C, Ikezoe T, Yang J, et al. Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene. Leukemia 2010; 24: 1631-40.
21. Matsuo Y, MacLeod RA, Uphoff CC, et al. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia 1997; 11: 1469-77.
22. Asou H, Tashiro S, Hamamoto K, et al. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-6.
23. Nishioka C, Ikezoe T, Yang J, et al. Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1. Apoptosis 2010; 15: 795-804.
24. Kube D, Platzer C, Von Knethen A, et al. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1-7.
25. Nishioka C, Ikezoe T, Yang J, et al. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway. Leukemia 2007; 21: 1044-9.
26. Tang JZ, Zuo ZH, Kong XJ, et al. Signal transducer and activator of transcription 5A and STAT5B differentially regulated human mammary carcinoma cell behavior. Endocrinology 2010; 151: 43-55.
27. Grimley PM, Dong F, Rui H., Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 1999; 10: 131-57.
28. Kang YJ, Yang SJ, Park G, et al. A novel function of interleukin-10 promoting self-renewal of hematopoietic stem cells. Stem Cells 2007; 25: 1814-22.
29. Wagner T, Fritsch G, Thalhammer R, et al. IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+ cells. Transfusion 2001; 41: 659-66.
30. Zou J, Zou P, Wang J, et al. Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol 2012; 91: 813-23.